{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Peptide Show","title":"Conrad Campbell: How do you build a peptide factory in China?","html":"","width":"100%","height":180,"duration":1398,"description":"How do peptides get from a factory in China to a price list in your DMs? \n\nConrad Campbell is a Scotsman building a peptide factory in China. \nAfter ten years in the military, he built businesses selling furniture, opening gyms, and trading online. Then he entered the peptide business, sourcing products from Chinese manufacturers for clients in the West.\nUnderstanding the supply chain gave him an idea: build a factory of his own. A fairly committed approach to checking your supplier.\nAlong the way, he learned how the gray market operates. He describes products leaving factories through the back door, passing through warehouses and middlemen, and being sold over WhatsApp. Plenty of people taking a cut. Rather less clarity about who takes responsibility.\nConrad says he wants to make that trade safer and more transparent. His ambitions sit within a much bigger story: empty biotech parks built for future demand, manufacturers planning decades ahead, and a Chinese industry he believes the US will struggle to catch.\nHe explains:\n\n■ Building a peptide factory in China\n■ The gray market’s back doors and middlemen\n■ What purity tests don’t tell you\n■ Inside China’s empty biotech parks\n■ Why America could spend billions and still trail China\nChapters\n\n\n\nFurther reading\n\nResearch: A study of Chinese suppliers advertising GLP-1 medicines online, including their marketing, shipping, and quality claims: Made in China: The international supply of illicit semaglutide and weight-loss medicines online.\nJAMA Network Open: A 2024 study testing semaglutide purchased online without a prescription for drug content, purity, and contamination: Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases.\nFDA: Manufacturing standards, quality controls, and why testing a finished product is only part of the process: Facts About Current Good Manufacturing Practice.\nFDA: Current concerns around unapproved GLP-1 drugs, including products sold directly to consumers under...","thumbnail_url":"https://img.transistorcdn.com/QcXtaDr9qe6jHT4c0BxQri4VufvdedcvMTMLmbuyqSA/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mZTg2/YmYyODMzN2NhMDNh/NzMzZGUxMzJhNDFj/YjVmMS5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}